|
|
Antibodies, antigens, and molecular mimicry
|
1989
|
1
|
|
Antibodies Applications and New Development
|
|
2
|
|
Antibodies as Cancer Immunotherapy / / Devalingam Mahalingam and Tyler J. Curiel --
|
2013
|
1
|
|
Antibodies as Tools to Probe Prion Protein Biology / / R. A. Williamson, D. R. Burton and D. Peretz /[et al.].17.
|
1999
|
1
|
|
Antibodies (Basel)
|
2012-
|
1
|
|
Antibodies (Basel)
|
2012-
|
1
|
|
Antibodies (Basel, Switzerland)
|
2012-
|
1
|
|
Antibodies biotinylated via sugar moieties / / Daniel J. O'Shannessy, Meir Wilchek and Edward A. Bayer --
|
1990
|
1
|
|
Antibodies for treating cancer : basics, development, and applications
|
2021
|
1
|
|
Antibodies in Transplantation : The Effects of HLA and Non- HLA Antibody Binding and Mechanisms of Injury / / Nicole M. Valenzuela and Elaine F. Reed --
|
2013
|
1
|
|
Antibodies to keratin and associated intermediate filaments in rheumatoid arthritis and other connective tissue diseases / / David L. Scott, Pekka Kurki --
|
1996
|
1
|
|
Antibodies to metallothionein / / Justine S. Garvey, James F. Riordan and Bert L. Vallee --
|
1991
|
1
|
|
The antibodies. Vol. 7
|
2002
|
1
|
|
Antibody array as a tool for screening of natural agents in cancer chemoprevention / / Claudio Pulito [and others] --
|
2016
|
1
|
|
Antibody Array Generation and Use
|
2014
|
1
|
|
Antibody arrays : methods and protocols
|
2021
|
1
|
|
Antibody-Based Biosensors -- / 6.1.2.4.
|
2011
|
1
|
|
Antibody-based detection of global nuclear DNA methylation in cells, tissue sections, and mammalian embryos / / Nathalie Beaujean, Juliette Salvaing, Nur Annies Abd Hadi, and Sari Pennings --
|
2018
|
1
|
|
Antibody-based latex agglutination assay / / Catherine M. Logue /Chantal W. Nde --6.6.4.2.
|
2017
|
1
|
|
Antibody-based microarrays / / Christer Wingren and Carl A.K. Borrebaeck --
|
2009
|
1
|
|
Antibody-based proteomic analysis of apoptosis signaling / / Matthew P. Stokes, Hongbo Gu, and Jeffrey C. Silva --
|
2016
|
1
|
|
Antibody-Based Therapies in Multiple Myeloma / / Yu-Tzu Tai --
|
2013
|
1
|
|
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
|
2016
|
1
|
|
Antibody biomarker discovery via in vitro evolution of peptides / / John T. Ballew, Jack R. Reifert, and Patrick S. Daugherty --
|
2018
|
1
|
|
Antibody-capture enzyme-linked immunosorbent assay for detection of antibody to turkey coronavirus using infectious bronchitis virus or recombinant nucleocapsid protein as coating antigen / / Chien Chang Loa [and others] --
|
2016
|
1
|
|
Antibody-carbohydrate recognition from docked ensembles using the AutoMap procedure / / Tamir Dingjan, Mark Agostino, Paul A. Ramsland, and Elizabeth Yuriev --
|
2015
|
1
|
|
Handbook of computational neurodegeneration /
|
2020
|
1
|
|
Antibody colocalization microarray for cross-reactivity-free multiplexed protein analysis / / Véronique Laforte, Pik-Shan Lo, Huiyan Li, and David Juncker --
|
2017
|
1
|
|
Antibody-conjugated single quantum dot tracking of membrane neurotransmitter transporters in primary neuronal cultures / / Danielle M. Bailey, Oleg Kovtun, and Sandra J. Rosenthal --
|
2017
|
1
|
|
Antibody-Cytokine Fusion Proteins with Members of the TNF-Family / / Dafne Müller and Jeannette Gerspach -- 10.
|
2010
|
1
|
|
Antibody deficiency --
|
2010
|
1
|
|
Diabetes and viruses /
|
2013
|
1
|
|
Antibody Detection -- / 10.4.
|
2015
|
1
|
|
Antibody Detection: Principles and Applications / / Yun F. (Wayne) Wang and Miwako Kobayashi --
|
2013
|
1
|
|
Antibody Development and Use in Chromogenic and Fluorescent Immunostaining / / Eamon Dubaissi [and others] --
|
2012
|
1
|
|
Antibody Directed Delivery for Treatment of Cancer: Antibody Drug Conjugates and Immunotoxins / / Pamela A. Trail --
|
2013
|
1
|
|
Antibody discovery using microfluidic systems / / Karolis Simutis, Greta Stonyte and Linas Mažutis --
|
2019
|
1
|
|
Antibody-Drug Conjugate Development / / Aakanksha Khandelwal, Haleh Saber, Marjorie A. Shapiro, Hong Zhao --
|
2013
|
1
|
|
Antibody-drug conjugates
|
2013
|
1
|
|
Antibody-drug conjugates and cellular metabolic dynamics
|
2023
|
1
|
|
Antibody-drug conjugates and immunotoxins : from pre-clinical development to therapeutic applications
|
2013
|
1
|
|
Antibody-Drug Conjugates: Can Coupling Cytotoxicity and Specificity Overcome Therapeutic Resistance? / / Penelope M. Drake, David Rabuka
|
2013
|
1
|
|
Antibody-Drug Conjugates for Hematologic Malignancies --
|
2013
|
1
|
|
Antibody-Drug Conjugates for Solid Tumors --
|
2013
|
1
|
|
Antibody-Drug Conjugates for the Treatment of B-Cell Malignancies / / Andrew G. Polson --
|
2013
|
1
|
|
Antibody-Drug Conjugates : Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer
|
2016
|
1
|
|
Antibody-drug conjugates : methods and protocols
|
2020
|
1
|
|
Antibody drug discovery
|
2012
|
1
|
|
Antibody engineering
|
1995
|
1
|
|
Antibody engineering : methods and protocols
|
|
3
|
Add Marked to Bag
Add All On Page
Add Marked to My Lists
|